XJPX
7506
Market cap40mUSD
Oct 09, Last price
1,371.00JPY
1D
0.51%
1Q
-1.01%
Jan 2017
-10.10%
IPO
-19.82%
Name
House of Rose Co Ltd
Chart & performance
P/E
3,860.50
P/S
0.56
EPS
0.36
Div yield, %
1.83%
Shrs. gr., 5y
—
Rev. gr., 5y
1.56%
Revenues
11.54b
-0.45%
Net income
2m
-97.90%
CFO
-144m
L
Dividend
Mar 30, 202712.5 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Tokyo, Japan, HOUSE OF ROSE Co.,Ltd. operates a chain of cosmetic retail stores throughout the country. These outlets offer an extensive selection of products, encompassing skincare, makeup, body and hair care essentials, bath items, fragranced body cosmetics, and subtly scented sundry goods, among other beauty supplies. In addition to its core cosmetic business, the company manages relaxation salons and operates fitness centers specifically for women under the Curves brand. By March 31, 2022, the firm had established a network of 248 locations in total, including 204 HOUSE OF ROSE stores, 21 Curves facilities, 17 relaxation salons, and 6 other retail establishments. The company itself was founded in 1978.
Key people
Harutoshi Kanno
Chairman of the Board of Directors · since 2022
Naoyuki Ban
Senior Managing Executive Officer, Director · since 2025
Yoshihiro Kawaguchi
President, Chief Director of Sales, Representative Director · since 2025
Michiko Suzuki
Business Executive Officer, Director of Director Store Sales · since 2025
Toshitake Ono
Manager of Business Planning Office, Director · since 2022
Satoshi Sato
Chief Director of Administration, Director · since 2022
Tatsuhiko Ikeda
Director · since 2025
Keiko Kishimoto
Business Executive Officer, Chief Director of Marketing, Chief Director of Sales Education, Director · since 2025
Shinichi Kitagawa
Independent Director · since 2021
Mayu Machida
Independent Director · since 2019
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||